0001140361-18-004481.txt : 20180201
0001140361-18-004481.hdr.sgml : 20180201
20180201164817
ACCESSION NUMBER: 0001140361-18-004481
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180130
FILED AS OF DATE: 20180201
DATE AS OF CHANGE: 20180201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PHASE4 VENTURES III LP
CENTRAL INDEX KEY: 0001687344
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 18567445
BUSINESS ADDRESS:
STREET 1: C/O PHASE4 PARTNERS LIMITED
STREET 2: 50 LOTHIAN ROAD, FESTIVAL SQUARE
CITY: EDINBURGH
STATE: X0
ZIP: EH39WJ
BUSINESS PHONE: 617-415-4774
MAIL ADDRESS:
STREET 1: C/O ALBIREO PHARMA, INC.
STREET 2: 50 MILK STREET, 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PHASE4 VENTURES III GENERAL PARTNER Ltd
CENTRAL INDEX KEY: 0001687418
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 18567446
BUSINESS ADDRESS:
STREET 1: C/O PHASE4 PARTNERS LIMITED
STREET 2: 50 LOTHIAN ROAD, FESTIVAL SQUARE
CITY: EDINBURGH
STATE: X0
ZIP: EH39WJ
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: C/O ALBIREO PHARMA, INC.
STREET 2: 50 MILK STREET, 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER NAME:
FORMER CONFORMED NAME: PHASE4 GENERAL PARTNER Ltd
DATE OF NAME CHANGE: 20161013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Phase4 Partners Ltd
CENTRAL INDEX KEY: 0001600023
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 18567447
BUSINESS ADDRESS:
STREET 1: GREEN PARK HOUSE
STREET 2: 15 STRATTON STREET
CITY: LONDON
STATE: X0
ZIP: W1J 8LQ
BUSINESS PHONE: 44 0 20 3036 0050
MAIL ADDRESS:
STREET 1: GREEN PARK HOUSE
STREET 2: 15 STRATTON STREET
CITY: LONDON
STATE: X0
ZIP: W1J 8LQ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
form4.xml
FORM 4
X0306
4
2018-01-30
true
0001322505
ALBIREO PHARMA, INC.
ALBO
0001600023
Phase4 Partners Ltd
1 CAVENDISH PLACE
LONDON
X0
W1G 0QF
UNITED KINGDOM
true
0001687418
PHASE4 VENTURES III GENERAL PARTNER Ltd
50 LOTHIAN ROAD, FESTIVAL SQUARE
EDINBURGH
X0
EH3 9WJ
UNITED KINGDOM
true
0001687344
PHASE4 VENTURES III LP
1 CAVENDISH PLACE
LONDON
X0
W1G 0QF
UNITED KINGDOM
true
Common Stock
2018-01-30
4
S
0
98500
34.4006
D
1066947
I
Held by Phase4 Ventures III GP LP
Common Stock
2018-01-30
4
S
0
1500
37.0587
D
1065447
I
Held by Phase4 Ventures III GP LP
The number of securities reported represents an aggregate number of shares sold in multiple market transactions over a range of sale prices. The Reporting Persons undertake to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Persons at each separate price within the range.
Sale prices range from $34.40 to $34.71, inclusive.
Sale prices range from $36.60 to $37.43, inclusive.
Consists of shares held by Phase4 Ventures III GP LP ("Phase4 GPLP") in its capacity as general partner of Phase4 Ventures III LP ("Phase4 III"). Phase4 GPLP is the general partner of Phase4 III. The general partner of Phase4 GPLP is Phase 4 Ventures III General Partner Limited ("Phase4 GP"). Phase4 GP has appointed Phase4 Partners Limited ("Phase4 Partners") to act as the manager of Phase4 III. Dr. Alastair McKinnon, Denise Scots-Knight, PhD, and Charles Sermon are Directors of Phase4 Partners (the "Phase4 Directors"). Each of the Phase4 Directors, Phase4 Partners, Phase4 GP, Phase 4 GPLP and Phase4 III may be deemed to beneficially own the shares held by Phase4 GPLP in its capacity as general partner of Phase4 III, but disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any.
/s/ Charles Sermon, Director, Phase4 Partners Limited
2018-02-01
/s/ Charles Sermon, Director, Phase4 Ventures III General Partner Limited
2018-02-01
/s/ Charles Sermon, Director, Phase4 Ventures III LP
2018-02-01